The global parenteral nutrition market is anticipated to expand due to the increasing prevalence of malnutrition among youngsters. For instance, 1.9 billion adults worldwide are overweight or obese, whereas 462 million adults are underweight, according to a World Health Organization and United Nations Children's Fund (UNICEF) article released on June 9, 2021 and 2020, respectively. According to the same source, 149 million children under the age of five were estimated to be stunted, 45 million were estimated to be wasted, and 38.9 million were overweight or obese in 2020. Additionally, it was reported that approximately 45% of deaths among children under the age of five are primarily caused by undernutrition.
The global Parenteral Nutrition Market is estimated to be valued at US$ 4,133.6 Mn in 2021, and is expected to exhibit a CAGR of 5.2 % over the forecast period (2021-2028).
Prominent Companies in the Parenteral Nutrition Industry:
1. B. Braun Melsungen AG
Founded in 1839, B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. It has headquarters situated in Bethlehem, Pennsylvania. In March, 2022 B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates.
2. Baxter International, Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. The company is operational in more than 100 countries.
3. Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. on December 2022, Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial, early and deep responses, and a manageable safety profile for elranatamab in heavily pretreated patients with advanced multiple myeloma.
4. Grifols, S.A.
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. It has headquarters situated in Barcelona, Spain has a presence in more than 30 countries.
5. Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois. It is operational in more than 100 countries.
6. Otsuka Pharmaceutical India Pvt. Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
7. JW Pharmaceutical
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. The company was founded in 1945 and is headquartered in Seoul, South Korea. In July, 2022 JW Group announced on the 6th that it has signed an agreement with ARCH Venture Partners, a U.S. venture capitalist (VC), to strengthen the promotion of open innovation strategies with global buyer companies.
8. Aculife Healthcare
Aculife has been associated with the healthcare segment which is the prime reason why the name spells unparalleled growth and absolute reliability. It has headquarters situated in Gujarat, India.
*Definition- The medical term for injecting a specific diet into a vein is parenteral nutrition (intravenously). The treatment's aim is to treat or stop malnutrition.
